Trials / Completed
CompletedNCT01188655
Observational Non-Interventional Study With Enbrel (Etanercept) in Patients With Ankylosing Spondylitis
Observational Non-Interventional Study With Enbrel in Patients With Ankylosing Spondylitis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 89 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This observational study will be a documentation of the prescribing and administration practices of Enbrel® and their impact on ankylosing spondylitis patients outcome in a real life setting.
Detailed description
The study population will be described using standard descriptive statistics for demographic, clinical, medical, characteristics, as well as for standard health-related quality of life and functional disability questionnaires .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Enbrel | The patients will be treated in accordance with the requirements of the labeling of Enbrel® in Austria. The dosage and duration of therapy is to be determined by the physician to meet the patients' individual needs for treatment. To record complete dosing information, initial dose will be documented at baseline and any change will be documented with date, dose and reason at the subsequent visits. |
Timeline
- Start date
- 2008-05-01
- Primary completion
- 2010-03-01
- Completion
- 2010-03-01
- First posted
- 2010-08-25
- Last updated
- 2011-09-12
- Results posted
- 2011-04-26
Source: ClinicalTrials.gov record NCT01188655. Inclusion in this directory is not an endorsement.